IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens
Aim. Eradication of hepatitis C virus (HCV) is still challenging even if interferon- (IFN-) free regimens with direct-acting antiviral agents (DAAs) for HCV-infected individuals are available in clinical practice. IFNL4 is a newly described protein, associated with human antiviral defenses. We inves...
Saved in:
| Main Authors: | Tatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, Makoto Arai, Masato Nakamura, Shuang Wu, Xia Jiang, Reina Sasaki, Yuki Haga, Shin Yasui, Yoshihiko Ooka, Tetsuhiro Chiba, Fumio Imazeki, Shigeru Mikami, Osamu Yokosuka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2014/723868 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin
by: Refaat Sadeq, et al.
Published: (2013-11-01) -
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
by: Chao-Min Huang, et al.
Published: (2017-01-01) -
IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.
by: Eleonora Lalle, et al.
Published: (2014-01-01) -
Thermal Inactivation of Hepatitis E Virus: A Narrative Review
by: Tatsuo Kanda, et al.
Published: (2025-05-01) -
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection
by: Serena Vita, et al.
Published: (2020-01-01)